RDM1 Polyclonal Antibody

Rabbit Anti-RDM1 Polyclonal Antibody

Product Specifications

Background

RDM1 encodes RAD52 motif containing 1 involved in the cellular response to cisplatin, a drug commonly used in chemotherapy. The RAD52 motif containing 1 encoded by RDM1 contains two motifs: a motif found in RAD52, a protein that functions in DNA double-strand breaks and homologous recombination, and an RNA recognition motif (RRM) that is not found in RAD52. The RAD52 motif region in RAD52 is important for protein function and may be involved in DNA binding or oligomerization. Alternatively spliced transcript variants encoding different isoforms have been reported.

CAS Number

9007-83-4

Product Name Alternative

RDM1; RAD52B; RAD52 motif-containing protein 1; RAD52 homolog B

Gene ID

201299

Accession Number

Q8NG50

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the Internal region of human RDM1 at AA rangle: 90-170

Clonality

Polyclonal

Tag

RAD52 motif-containing protein 1

Applications

IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

RDM1 Polyclonal Antibody detects endogenous levels of RDM1 protein.

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300; ELISA 1:5000; IF 1:50-200